European Primary Care Cardiovascular Society

GLP-1RA reduces risk of CV events associated with overweight and obesity

3' education - Jan. 2, 2024 - Michael Lincoff, MD - Cleveland, OH, US

Educational information

This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, US.


Michael Lincoff, MD is an interventional cardiologist and Vice Chairman for Research of the Department of Cardiovascular Medicine at the Cleveland Clinic in Cleveland, OH, US. He is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research.


This recording was developed under auspices of EPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of EPCCS.

Read a summary of the SELECT trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: